IRIS Accounts Production v25.1.4.42 00331798 director 1.10.23 30.9.24 30.9.24 false true false false true false Fair value model iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 00331798 2023-09-30 00331798 2024-09-30 00331798 2023-10-01 2024-09-30 00331798 2022-09-30 00331798 2022-10-01 2023-09-30 00331798 2023-09-30 00331798 ns15:EnglandWales 2023-10-01 2024-09-30 00331798 ns14:PoundSterling 2023-10-01 2024-09-30 00331798 ns10:Director1 2023-10-01 2024-09-30 00331798 ns10:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 00331798 ns10:SmallEntities 2023-10-01 2024-09-30 00331798 ns10:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 00331798 ns10:SmallCompaniesRegimeForDirectorsReport 2023-10-01 2024-09-30 00331798 ns10:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 00331798 ns10:FullAccounts 2023-10-01 2024-09-30 00331798 ns10:RegisteredOffice 2023-10-01 2024-09-30 00331798 ns5:CurrentFinancialInstruments 2024-09-30 00331798 ns5:CurrentFinancialInstruments 2023-09-30 00331798 ns5:ShareCapital 2024-09-30 00331798 ns5:ShareCapital 2023-09-30 00331798 ns5:FurtherSpecificReserve3ComponentTotalEquity 2024-09-30 00331798 ns5:FurtherSpecificReserve3ComponentTotalEquity 2023-09-30 00331798 ns5:RetainedEarningsAccumulatedLosses 2024-09-30 00331798 ns5:RetainedEarningsAccumulatedLosses 2023-09-30 00331798 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-09-30 00331798 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-09-30 00331798 ns5:RetainedEarningsAccumulatedLosses 2023-09-30 00331798 ns5:FurtherSpecificReserve3ComponentTotalEquity 2023-09-30 00331798 ns5:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30

REGISTERED NUMBER: 00331798 (England and Wales)

| Unaudited Financial Statements |

| for the Year Ended 30 September 2024 |

| for |

| Spital Developments Limited |

| Spital Developments Limited (Registered number: 00331798) |

Contents of the Financial Statements

for the Year Ended 30 September 2024

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| Spital Developments Limited |

Company Information

for the Year Ended 30 September 2024

| DIRECTOR: | Miss V L Wale

| REGISTERED OFFICE: | The Cruck Barn

| Hollins

| Old Brampton

| Chesterfield

| Derbyshire

| S42 7JH

| REGISTERED NUMBER: | 00331798 (England and Wales)

| ACCOUNTANTS: | Bates Weston LLP

| Chartered Accountants

| The Mills

| Canal Street

| Derby

| DE1 2RJ

| Spital Developments Limited (Registered number: 00331798) |

Balance Sheet

30 September 2024

| 2024 | 2023 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Investment property | 4 | 2,910,000 |  | 2,805,000 |  |

CURRENT ASSETS

Debtors | 5 | 20,417 |  | 9,492 |  |

Cash at bank | 147,415 |  | 64,226 |  |

167,832 |  | 73,718 |  |

CREDITORS

Amounts falling due within one year | 6 | 108,806 |  | 112,736 |  |

NET CURRENT ASSETS/(LIABILITIES) | 59,026 |  | (39,018 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 2,969,026 |  | 2,765,982 |  |

PROVISIONS FOR LIABILITIES | 79,499 |  | 40,469 |  |

NET ASSETS | 2,889,527 |  | 2,725,513 |  |

CAPITAL AND RESERVES

Called up share capital | 3,280 |  | 3,280 |  |

Fair value reserve | 7 | 949,591 |  | 883,621 |  |

Retained earnings | 7 | 1,936,656 |  | 1,838,612 |  |

2,889,527 |  | 2,725,513 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

| Spital Developments Limited (Registered number: 00331798) |

Balance Sheet - continued

30 September 2024

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 June 2025 and were signed by:

Miss V L Wale - Director

| Spital Developments Limited (Registered number: 00331798) |

Notes to the Financial Statements

for the Year Ended 30 September 2024

1. | STATUTORY INFORMATION

| Spital Developments Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

| Turnover

| Turnover is the invoiced value of rents receivable during the period and is recognised in the period in which the property is occupied.

| Investment property

| Investment property is not depreciated but is revalued annually at it's fair value in accordance with the Financial Reporting Standard 102 (Section 1A). Any aggregate surplus or deficit arising from changes in fair value is recognised in the profit and loss account and transferred to a fair value reserve.

| Deferred taxation

| Provision is made at current rates for taxation deferred in respect of all material timing differences, including provisions made for potential tax arising on assets which have been revalued.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2023 - 1 ) .

4. | INVESTMENT PROPERTY

| Total

£ |

| FAIR VALUE

| At 1 October 2023 | 2,805,000 |  |

| Revaluations | 105,000 |  |

| At 30 September 2024 | 2,910,000 |  |

| NET BOOK VALUE

| At 30 September 2024 | 2,910,000 |  |

| At 30 September 2023 | 2,805,000 |  |

| Fair value at 30 September 2024 is represented by:

£ |

| Valuation in 2024 | 2,910,000 |  |

| Spital Developments Limited (Registered number: 00331798) |

Notes to the Financial Statements - continued

for the Year Ended 30 September 2024

4. | INVESTMENT PROPERTY - continued

| If investment property had not been revalued it would have been included at the following historical cost:

2024 | 2023 |

£ | £ |

| Cost | 1,880,910 |  | 1,880,910 |  |

| Aggregate depreciation | (605,404 | ) | (567,786 | ) |

| Investment property was valued on a fair value basis on 30 September 2024 by the Directors .

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Trade debtors | 2,277 |  | 3,670 |  |

| Prepayments | 18,140 |  | 5,822 |  |

20,417 |  | 9,492 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2024 | 2023 |

£ | £ |

| Trade creditors | 41,447 |  | 26,544 |  |

| Tax | 36,160 |  | 33,128 |  |

| Directors' current accounts | 17,399 |  | 35,387 |  |

| Accrued expenses | 13,800 |  | 17,677 |  |

108,806 |  | 112,736 |  |

7. | RESERVES

| Fair |

| Retained |  | value |

| earnings |  | reserve |  | Totals

£ | £ | £ |

| At 1 October 2023 | 1,838,612 |  | 883,621 |  | 2,722,233 |  |

| Profit for the year | 180,414 |  | 180,414 |  |

| Dividends | (16,400 | ) | (16,400 | ) |

| Revaluation | (65,970 | ) | 65,970 |  | - |  |

| At 30 September 2024 | 1,936,656 |  | 949,591 |  | 2,886,247 |  |